Personal information

No personal information available

Activities

Collapse all

Employment (1)

Frederick National Laboratory for Cancer Research: Frederick, Maryland, US

Employment
Source: Self-asserted source
Dana Rabara

Works (4)

Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR

Journal of Biological Chemistry
2024-02 | Journal article
DOI: 10.1016/j.jbc.2024.105650
Contributors: Alok K. Sharma; Jun Pei; Yue Yang; Marcin Dyba; Brian Smith; Dana Rabara; Erik K. Larsen; Felice C. Lightstone; Dominic Esposito; Andrew G. Stephen et al.
Source: check_circle
Crossref

Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.

The Journal of biological chemistry
2019-12-13 | Journal article
DOI: 10.1074/jbc.ra119.010934
PMID: 31836666
PMC: PMC6983858
Contributors: Mukul Sherekar; Han SW; Rodolfo Ghirlando; Messing S; Drew M; Rabara D; Waybright T; Puneet Juneja; Hugh O'Neill; Christopher Stanley et al.
Source: Self-asserted source
Dana Rabara

KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis.

Proceedings of the National Academy of Sciences of the United States of America
2019-10-14 | Journal article
DOI: 10.1073/pnas.1908353116
PMID: 31611389
PMC: PMC6825300
Contributors: Rabara D; Timothy Tran; Srisathiyanarayanan Dharmaiah; Stephens RM; McCormick F; Dhirendra Simanshu; Matthew Holderfield
Source: Self-asserted source
Dana Rabara

Label-Free Time-Gated Luminescent Detection Method for the Nucleotides with Varying Phosphate Content.

Sensors (Basel, Switzerland)
2018-11-16 | Journal article
DOI: 10.3390/s18113989
PMID: 30453509
PMC: PMC6264117
Contributors: Kari Kopra; Seppälä T; Rabara D; Abreu-Blanco M; Kulmala S; Matthew Holderfield; Härmä H
Source: Self-asserted source
Dana Rabara
How many people are using ORCID?